• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Novartis Invests in Credence MedSystems

    Ajinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement

    Almac Expands Global Biologics Testing Solutions

    GRAM Makes Major Investment in Additional Advanced Equipment

    Adare Pharma Solutions Opens New Small-Scale Lab
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Ajinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement

    GRAM Makes Major Investment in Additional Advanced Equipment

    Aphena’s $21M Cookeville Expansion Nears Completion

    PromoCell Receives EXCiPACT Certification

    Civica to Build an Essential Medicines Manufacturing Facility in Virginia
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Novartis Invests in Credence MedSystems

    Aphena’s $21M Cookeville Expansion Nears Completion

    Civica to Build an Essential Medicines Manufacturing Facility in Virginia

    WDSrx Expands Warehouse Network

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Almac Expands Global Biologics Testing Solutions

    The State of Clinical Trial Technology

    Adare Pharma Solutions Opens New Small-Scale Lab

    The Future of Clinical Trials Series: Part II

    X-Chem Acquires IntelliSyn and AviSyn
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Alcami

    Reed-Lane

    Almac Group

    PCI Pharma Services
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Cytovance Biologics

    Adare Pharma Solutions

    PCI Pharma Services

    Syngene

    Almac Group
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Pharma Supply Chain Logistics & Potential COVID-19 Vaccines

    Wes Wheeler of UPS Healthcare explores various complexities, how to minimize supply chain gaps and challenges across the nation and globally.

    Pharma Supply Chain Logistics & Potential COVID-19 Vaccines
    Related CONTENT
    • The State of Clinical Trial Technology
    • Adare Pharma Solutions Opens New Small-Scale Lab
    • Aphena’s $21M Cookeville Expansion Nears Completion
    • Humanigen, Emergent Enter Covid-19 Partnership
    • Pfizer, BioNTech Enter Vax Pact with COVAX
    Kristin Brooks, Contract Pharma09.17.20

    With the first potential COVID-19 vaccine(s), anticipated as soon as late this year, supporting pharmaceutical manufacturers and distributors to ensure a strong continuum of efficient supply chain logistics will be essential.

    Logistics plays a vital role in vaccine development and delivery. Market demands, international travel and supply chain restrictions, and temperature-sensitive products, add further complexities into the mix.

    UPS Healthcare president, Wes Wheeler, discusses logistics’ role in vaccine development and linking healthcare workers and patients to medicines, as well as how the pandemic is impacting pharmaceutical supply chain logistics, and challenges that may arise with the supply and distribution of a potential COVID-19 vaccine. –KB 

    Contract Pharma: How is the pandemic impacting pharmaceutical supply chain logistics?

    Wes Wheeler: Complexities in the pharmaceutical supply chain have been magnified by the COVID-19 pandemic. Early on in the outbreak, international travel and supply chain restrictions hampered the throughput of essential medications, equipment and test kits, leading to supply shortages worldwide. Market demands will continue to drive a need for certified healthcare-dedicated logistics services, including strict environments for temperature-sensitive products such as vaccines. The pandemic is reshaping the healthcare industry, and is heavily impacting global supply chains requiring unprecedented levels of logistics and distribution support.

    UPS Healthcare worked closely with federal agencies and global healthcare customers like QIAGEN, AmerisourceBergen, Amgen, Edwards Lifesciences, Dr. Reddy’s, Vault Health and others. The urgent mission was overcoming supply chain challenges and flight restrictions to expedite test kits, personal protection equipment, ventilators, ICU monitoring units, medical devices, and time- and- temperature-sensitive pharmaceuticals to hospitals and markets around the world. We expect to lend the same extensive support when it is time to distribute vaccines to populations around the globe in the coming months.

    CP: What role does logistics play in vaccine development and delivery? How important is packaging?

    WW: Logistics play a pivotal role in this battle against the coronavirus, including vaccine logistics, when it comes to that. Currently, our clinical subsidiary, Marken, is working with several pharmaceutical companies and their partners as their vaccines and treatments enter the clinical stages of development. Our involvement in the clinical phase gives us valuable data on how to manage the logistics for these complex products.

    Vaccines, like most sterile products, are usually packed by the customer according to strict FDA and other regulations. For outer packaging, vaccines that require -80°C handling are shipped in validated thermal coolers using dry ice. Vaccines that are shipped at -20°C or 2-8°C are shipped in validated thermal coolers that can be maintained for up to 96 hours. Vaccines shipped at -2°C to -8°C are packed in validated thermal containers that are either disposable or re-usable utilizing phase-change material. Handling such sensitive, critical products, whether specimens during clinical phase or vaccines, including mRNA types, once ready for market, requires smart, specialized networks and temperature controls that are optimized to mitigate loss, damage or spoilage. In the battle against this virus, understanding and planning for various supply chain complexities will make all the difference for a successful vaccine distribution campaign.

    CP: What challenges do you anticipate with the supply and distribution of a potential COVID-19 vaccine?

    WW: Among the challenges facing the industry will be prioritizing vaccine distribution - determining who gets the vaccine in what order, and secondly, perhaps what rationed amounts each of these demographics or countries receive. With manufacturing, one consideration is the availability of glass and other raw materials for billions of vials. On the logistics side, maintaining strict temperature controls while mitigating loss, damage and spoilage will be of paramount concern. The sheer uncertainty of vaccine development and approvals right now is a major consideration since planning detailed supply chain protocols for storage and distribution are simply “what if” scenarios at this point. Essentially, supply chains must plan for any and every scenario, and build in contingency plans to avoid supply chain failures.

    Internationally, countries will need to adopt collaborative and cooperative cultures like never before surrounding COVID vaccine distribution to avoid regulatory or political bottlenecks. Demand likely will outpace supply with initial vaccine deployments, so we cannot afford to lose one vial because lives will depend on supply chains being prepared, efficient and agile end-to-end on day one.

    CP: What services are being leveraged to alleviate these hurdles?

    WW: UPS is in discussions with U.S. Health & Human Services, the Operation Warp Speed team and our partners to think through various complexities, and explore how to minimize supply chain gaps and challenges across the nation and globally. UPS Healthcare recently brought online more than 1.5 million additional square feet of cGMP healthcare distribution space in key global markets, including the UK, Hungary, Shanghai and the U.S., and installing two freezer farms in Louisville, Kentucky, and Roermond-Venlo, the Netherlands, for vaccine storage and distribution. The freezers will be capable of holding therapies under quarantine, prior to FDA issue of an Emergency Use Authorization (EUA). We expect that some of the vaccine developers will manufacture at risk, ahead of EUA, in anticipation of approval.

    UPS Premier, our priority handling service, will play a key role in enabling urgent flow paths, monitoring and contingency actions. This service will give our stakeholders superb visibility and control over critical COVID-19 vaccine shipments, taking the guesswork out of shipment status and condition anywhere in the world. Furthermore, new command centers in Louisville and Roermond will be nerve centers to track shipments using GPS markers along the supply chain, and staffed to monitor for temperature deviations, intervention and re-icing protocols if needed to keep products safe and stable.

    CP: What does direct-to-patient logistics entail in these times?

    WW: When clinical sites and hospitals needed to refocus on COVID-related treatments and testing, Marken’s services allowed patients to continue with their trials through home visits. Direct to/from Patient (DTP/DFP) and home healthcare services provide solutions to keep clinical trials going, while maintaining patient safety by shipping treatments directly to participants’ homes.

    Through DFP services, biological samples are retrieved from a patient’s home and sent to laboratories for testing. Combining DTP services with home healthcare services allows patients to respect the confinement guidelines of their location while continuing to participate in their clinical trial, which is key in the development of critical therapies and vaccines. Prior to the pandemic, Marken was operating direct-to-patient in 57 countries. Now, that service has been provided in over 80 countries. After sponsors secure permission to include DTP services into their protocols, Marken coordinates logistics and delivery of thousands of clinical drug products directly to patients participating in trials throughout Asia, Europe, the U.S. and Latin America.
     


    Wes Wheeler is president of UPS Healthcare, the company’s first vertical business unit and is specifically focused on pharmaceuticals, medical devices, wholesalers, retail distributors and customers that store or move regulated healthcare products. Prior to taking this role in 2019, Wes was the Chief Executive Officer of Marken, a leading global supply chain service provider to the clinical supply chain industry serving all of the leading pharmaceutical sponsors, central laboratories and contract research organizations in the world.


    Suggested For You
    The State of Clinical Trial Technology The State of Clinical Trial Technology
    Adare Pharma Solutions Opens New Small-Scale Lab Adare Pharma Solutions Opens New Small-Scale Lab
    Aphena’s $21M Cookeville Expansion Nears Completion Aphena’s $21M Cookeville Expansion Nears Completion
    Humanigen, Emergent Enter Covid-19 Partnership Humanigen, Emergent Enter Covid-19 Partnership
    Pfizer, BioNTech Enter Vax Pact with COVAX  Pfizer, BioNTech Enter Vax Pact with COVAX
    WDSrx Expands Warehouse Network WDSrx Expands Warehouse Network
    Global Biosciences Co. Selects ValGenesis VLMS  Global Biosciences Co. Selects ValGenesis VLMS
    Valeo Pharma Appoints President, COO Valeo Pharma Appoints President, COO
    Bioclinica Partners with Ikcon Pharma Bioclinica Partners with Ikcon Pharma
    Thermo Fisher Buys Novasep Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    Cytiva Delivers Modular Biologics Factory to Lonza Cytiva Delivers Modular Biologics Factory to Lonza
    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations Catalent Acquires Acorda’s INBRIJA Manufacturing Operations
    Capricor, Lonza Enter CAP-1002 Development Agreement Capricor, Lonza Enter CAP-1002 Development Agreement
    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact
    iosBio Inks Exclusive Vax Platform Pact for COVID-19 iosBio Inks Exclusive Vax Platform Pact for COVID-19

    Related Online Exclusives

    • Clinical Trials | Information Technology
      The State of Clinical Trial Technology

      The State of Clinical Trial Technology

      Blake Adams of Florence discusses key report findings and the clinical trial software used to support Pfizer’s global COVID-19 vaccine study.
      Kristin Brooks, Contract Pharma 01.26.21

    • Analytical Services | Laboratory Testing
      Improving Product Profitability

      Improving Product Profitability

      Using PAT/QbD/CM as tools to increase profitability of products.
      Emil Ciurczak, Contributing Editor 01.21.21

    • Analytical Services | Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Fill/Finish
      A New Era of Vaccine and Biologic Drug Development

      A New Era of Vaccine and Biologic Drug Development

      As a result of COVID-19, unprecedented investments in vaccines, diagnostics, and treatments have had a tremendous impact on the Biotechnology industry.
      Kristin Brooks, Managing Editor 01.12.21


    • Clinical Trials | Drug Development | Information Technology
      Advancing Digital Endpoints in Clinical Trials

      Advancing Digital Endpoints in Clinical Trials

      An end-to-end approach to managing wearable devices through clinical development.
      Kristin Brooks, Contract Pharma 12.14.20

    • Drug Delivery | Drug Development
      Inhaled Drug Delivery Technology Trends

      Inhaled Drug Delivery Technology Trends

      The success of new inhaled medicines relies on the correct combination of formulation and device technology.
      Dr. Sandy Munro, Vice President – Pharmaceutical Development, Vectura 11.24.20

    • Bioanalytical Services | cGMP Manufacture | Drug Development | Scale-up/Technology Transfer
      CDMOs: Keeping up with Science & Technology

      CDMOs: Keeping up with Science & Technology

      Enhancing the development of increasingly advanced and complex drug candidates is needed to drive growth in the industry.
      Kristin Brooks, Contract Pharma 11.12.20


    • Excipients
      Pharmaceutical Excipients Market Poised for Growth

      Pharmaceutical Excipients Market Poised for Growth

      The global pharmaceutical excipients market is estimated to surpass $11,944.6 million by 2027.
      Contract Pharma Staff 11.03.20

    • cGMP Manufacture | Fill/Finish | Scale-up/Technology Transfer
      Ramping Up COVID-19 Vaccine Fill and Finish Capacity

      Ramping Up COVID-19 Vaccine Fill and Finish Capacity

      As a partner to the U.S. Government, GRAM's newest facility was designed to increase large-scale fill and finish capacity with room to expand as demand grows.
      Kristin Brooks, Contract Pharma 11.03.20

    • Biologics, Proteins, Vaccines
      India Emerges as Hot Spot for Manufacturing COVID-19 Vaccines

      India Emerges as Hot Spot for Manufacturing COVID-19 Vaccines

      CMOs expand and ‘repurpose’ capacities.
      S Harachand, Contributing Editor 10.20.20


    • Clinical Trials | Drug Development | Preclinical Outsourcing
      Accelerating R&D Trends

      Accelerating R&D Trends

      The pandemic has propelled lingering trends into the forefront and increasingly complex molecules and biologics have drug developers outsourcing more.
      Kristin Brooks, Contract Pharma 10.20.20

    • Drug Delivery
      Topical Drugs Poised for Growth

      Topical Drugs Poised for Growth

      The topical drug delivery market is projected to reach $129.8 billion by 2025 from $95.2 billion in 2020, at a CAGR of 6.4%.
      Contract Pharma Staff 10.12.20

    • Drug Delivery
      Drug Delivery Market Report

      Drug Delivery Market Report

      The pharmaceutical drug delivery market was valued at $1,403,082.9 million in 2019 and is projected to reach $2,296,170.9 million by 2027.
      Contract Pharma Staff 10.12.20


    • Parenterals
      Primary Packaging Considerations Amid COVID-19 Vax Urgency

      Primary Packaging Considerations Amid COVID-19 Vax Urgency

      Fran L. DeGrazio of West discusses why and how vaccine development is different than drug development and the impacts of COVID-19 on vaccine development.
      Kristin Brooks, Contract Pharma 10.05.20

    • cGMP Manufacture
      Keeping Up with Continuous Biopharmaceutical Processing

      Keeping Up with Continuous Biopharmaceutical Processing

      Keith Fritsky discusses uptake among biomanufacturers and W. L. Gore’s perspective on operation of equipment in continuous processing.
      Kristin Brooks, Contract Pharma 09.11.20

    • COVID-19: Racing for a Vaccine

      COVID-19: Racing for a Vaccine

      Amélie Boulais of Sartorius discusses the landscape and challenges for developing a vaccine against the SARS-Cov-2 virus
      Kristin Brooks, Contract Pharma 09.09.20

    Trending
    • Integrated Continuous Manufacturing ICM
    • Humanigen, Emergent Enter Covid-19 Partnership
    • 500+ Sites Join Inato’s Industry Marketplace
    • Samsung Bioepis Opens New Headquarters
    • CDMO Northway Biotech Expands In U.S.
    Breaking News
    • Novartis Invests in Credence MedSystems
    • Ajinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement
    • Almac Expands Global Biologics Testing Solutions
    • GRAM Makes Major Investment in Additional Advanced Equipment
    • Adare Pharma Solutions Opens New Small-Scale Lab
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

      View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Omega-3s Evidenced to Reduce Low-Grade Inflammation in Elderly Men
    MIND and Mediterranean Diets Linked to Later Onset of Parkinson’s Disease
    Kerry Launches Web-Based Tool for Plant-Based Formulation Challenges
    Coatings World

    Latest Breaking News From Coatings World

    Keyland Polymer UV Powder, LLC Launches UVMax Defender
    Scott McLaughlin to Race in PPG Colors During Rookie INDYCAR Season
    Vink Chemicals Offers parmetol PSG
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Butterfly Network Appoints New Leader
    BD Names Chairman of Board
    Interplex Acquires OCP Group
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Novartis Invests in Credence MedSystems
    Ajinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement
    Almac Expands Global Biologics Testing Solutions
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Bésame Cosmetics Collaborates with Disney on Mary Poppins Collection
    The Estée Lauder Companies Announces Game-Changing Sustainability Goals for Travel Retail
    Aura Introduces Customizable Hair Care
    Happi

    Latest Breaking News From Happi

    L'Occitane US Files for Bankruptcy
    Nice-Pak Receives EPA Approval for Disinfectant Wipes
    Ecover Recalls Detergent in UK
    Ink World

    Latest Breaking News From Ink World

    Epson Partner Creates Label Applicators for Pharmaceutical Products
    Smurfit Kappa Sets New Sustainability Targets with Better Planet 2050
    Paragon Expands Direct Mail Capabilities with Ricoh Pro VC70000
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Great Lakes Label debuts new website
    Epson partner creates label applicators for pharmaceutical products
    ACTEGA removes chemicals from laminating adhesives
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    American Made Production Equipment for Mask Manufacturers
    Kimberly-Clark Releases Q4, Full Year Results
    Freudenberg to Establish Apparel Interlining Competence Centers
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Spinal Elements' Lucent XP-Curved Expandable TLIF Gains FDA Nod
    FDA OKs OrthoSpin's 2nd Gen Robotic, Digital External Fixation System
    Nextremity Solutions Enters Supply Agreement with Fort Wayne Metals
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    North American Semiconductor Equipment Industry Posts December 2020 Billings
    First Solar Signs Definitive Agreement to Sell US Development Platform to Leeward
    PRINTING United Alliance Announces TAGA Presents Virtual Event

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login